Our Pipeline
Our MasterKey therapies are designed to address broad genetically defined patient populations, overcome resistance, minimize wild-type mediated toxicities, and be brain penetrant to treat CNS disease. Our efforts are focused on non-small cell lung cancer (NSCLC) and glioblastoma (GBM).
VIEW OUR PIPELINEPatients
Our mission is to provide people living with cancer the opportunity to experience longer, healthier, and more active lives. We support patient advocacy groups focusing on non-small cell lung cancer (NSCLC) and glioblastoma (GBM). Learn MoreOur MasterKey Approach
Cancer is a complex and ever-evolving disease, yet current targeted therapies address a limited subset of oncogenic mutations. Our MasterKey approach aims to expand the addressable patient population by offering one solution for many mutations.